Atea Pharmaceuticals(AVIR) - 2023 Q2 - Earnings Call Transcript

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Jonae Barnes – Senior Vice President of Investor Relations and Corporate Communications Jean-Pierre Sommadossi – Chief Executive Officer and Founder Janet Hammond – Chief Development Officer Arantxa Horga – Chief Medical Officer Andrea Corcoran – Chief Financial Officer and Executive Vice President of Legal John Vavricka – Chief Commercial Officer Conference Call Participants Maxwell Skor ...